| 
| Entry date | September 24, 2002  12:00 +1GMT 
 |  | Last update | April 28, 2019  20:51 +1GMT 
 |  | Allergome Code | 71 
 |  | Name | Asp f 2   
 |  | Previous Names | Asp f II 
 |  | Common Names | Fibrinogen-binding Protein, m219 
 |  | Biological Function | Fibrinogen Binding Protein?, Fibrinogen-binding Proteins 
 |  | Isoforms, Variants, Epitopes
 | Asp f 2.0101 
 |  | Links to Molecule Sequences
 | Asp f 2 - B0Y6E9 - UNIPROT, Asp f 2 - D3W9Z7 - UNIPROT, Asp f 2.0101 - P79017 - UNIPROT 
 |  | Sources |  |  | Links to Source Taxonomy
 | Asp f - 746128 - NCBI, Asp f - 746128 - UniProt, Asp f - Discover Life, Asp f - Wikipedia 
 |  | Links to Source Images | Aspergillus fumigatus on Google images |  | Tissues | Whole Body 
 |  | Routes of Exposure | Inhalation 
 |  | Epidemiology from Literature
 | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography |  | 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 0.000 | 20120528, Patelis A |  | 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 15.000 | 20091005, Ott H |  | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ |  | 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG |  | 3.1.1 - Source Sensitized (SPT) | 1997 | United States | IgE | 10 | 10.000 | 1997, Banerjee B |  | 3.1.4 - Source Sensitized (SPT, IgE) | 2000 | Switzerland | IgE | 16 | 6.000 | 2000a, Kurup VP |  | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 0.000 | 20091121, Ebo DG |  | 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 0.000 | 20091121, Ebo DG |  | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 0.000 | 20090826, Ebo DG |  | 5.1.1 - Source Exposed (Symptoms) | 2002 | United States | IgE | 18 | 44.400 | 2002, McCann WA |  | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 1.010 | 20110223, De Knop KJ |  | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2007 | Germany | IgE | 8 | 100.000 | 20070305, RingerS |  | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2000 | Switzerland | IgE | 24 | 87.000 | 2000a, Kurup VP |  | 5.4.2 - Source Exposed (Symptoms, SPT, high IgE) | 1997 | United States | IgE | 25 | 100.000 | 1997, Banerjee B |  | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 0.270 | 20120528, Patelis A | 
 |  | References | Biochemistry / Structure / Function 2014:
 20140331, Lollier V
 2011:
 20110714, Gautam P
 2010:
 20101104, Fraczek MG
	 - 20100910, Singh B
	 - 20100303, Amich J
 2008:
 20081230, Cressman RF
	 - 20081028, Ivanciuc O
	 - 20080714, Oezguen N
	 - 20080411, Fedorova ND
	 - 20080128, Kanduc D
 2007:
 20070907, Soeria-Atmadja D
	 - 20070703, Gautam P
	 - 20070227, Bowyer P
 2006:
 20061017, Bowyer P
	 - 20060923, Westwood GS
	 - 20060704, Svirshchevskaya E
 2005:
 20051222, Nierman WC
 2004:
 20040201, Ivanciuc O
 2002:
 2002, Banerjee B
 2000:
 2000, Tang B
 ... complete Reference listing ->
 
 Molecular Biology
 2010:
 20100303, Amich J
 2002:
 2002, Banerjee B
 2000:
 2000, Tang B
 1999:
 1999, Banerjee B
 1998:
 1998, Banerjee B
 1996:
 1996, Banerjee B
 
 Immunochemistry / Allergenicity
 2013:
 20130820, Kespohl S
 2010:
 20100910, Singh B
 2008:
 20081028, Ivanciuc O
 2007:
 20070703, Gautam P
 2002:
 2002, Banerjee B
 2000:
 2000, Tang B
 1999:
 1999, Banerjee B
 1998:
 1998, Banerjee B
 1997:
 1997, Banerjee B
 1996:
 1996, Banerjee B
 1993:
 1993, Teshima R
 
 Immune-mechanisms / Genetics
 2003:
 20031213, Knutsen AP
 2001:
 2001, Rathore VB
 
 Detection - Source Extracts, Food Products, Drug Preparations
 2010:
 20101104, Fraczek MG
 1999:
 1999, Segurado M
 1998:
 1998, Banerjee B
 
 Detection - Allergy Diagnostic and Immunotherapeutic Products
 2013:
 20130820, Kespohl S
 
 Detection - Source Tissues
 2010:
 20100303, Amich J
 
 Epidemiology
 2012:
 20120528, Patelis A
 2011:
 20111214, Zheng YW
 2009:
 20090826, Ebo DG
 
 Diagnosis
 2014:
 20140609, Rentzos G
	 - 20140331, Rockmann H
	 - 20140324, Heaps A
 2013:
 20130820, Kespohl S
	 - 20130507, Agarwal R
	 - 20130129, Shokry D
 2012:
 20121004, Bonini M
	 - 20120725, Pascal M
	 - 20120720, Alessandri C
	 - 20120426, Sastre I
 2011:
 20110521, Melioli G
	 - 20110223, De Knop KJ
	 - 20110124, Postigo I
 2009:
 20091121, Ebo DG
	 - 20091005, Ott H
	 - 20090826, Ebo DG
	 - 20090210, Ohshima M
 2007:
 20070420, Giavina-Bianchi P
	 - 20070305, RingerS
 2006:
 20061019, Bowyer P
 ... complete Reference listing ->
 
 Experimental Model - Allergic Immune Response
 2006:
 20060704, Svirshchevskaya E
 2005:
 20051023, Rivera A
 
 Experimental Model - Inhalant-induced Diseases
 2005:
 20051103, Barrios CS
 2004:
 20040929, Svirshchevskaya EV
 2002:
 2002b, Kurup VP
	 - 2002, Bozza S
 2001:
 2001, Svirshchevskaya EV
 
 Review, Editorial, Report Citations, Other Resources
 2014:
 20141118, Heinekamp T
	 - 20140513, Singh B
	 - 20140416, Denning DW
	 - 20140304, Shah A
 2013:
 20131108, Agarwal R
	 - 20131004, Canonica GW
	 - 20130810, Kleine-Tebbe J
 2012:
 20120712, Bumbacea RS
	 - 20120501, Mahdavinia M
	 - 20120405, Durr C
	 - 20120402, Bhetariya PJ
	 - 20120305, Matsumura Y
	 - 20120130, Knutsen AP
	 - 20120111, Treudler R
 2011:
 20111228, Prester L
	 - 20111003, Knutsen AP
	 - 20110523, Knutsen AP
 2010:
 20101214, Alessandri C
	 - 20101111, Delhaes L
	 - 20101026, Abad A
 ... complete Reference listing ->
 |  |